Role of A and B blood group, antigens in the expression of adhesive activity of von Willebrand factor

British Journal of Haematology

Volumn 109, Issue 4, 2000, Pages 857-864

  Sarode, Ravindra ^a   Goldstein, Jack ^b   Sussman, Ira I ^c   Nagel, Ronald L ^c   Tsai, Han Mou ^c  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b NEW YORK BLOOD CENTER   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

ABO blood group; Bleeding disorder; Platelet; Ristocetin cofactor activity; Thrombosis; Von Willebrand factor

Indexed keywords

ALPHA GALACTOSIDASE; ALPHA N ACETYLGALACTOSAMINIDASE; BLOOD GROUP ANTIGEN; FRESH FROZEN PLASMA; RISTOCETIN; VON WILLEBRAND FACTOR;

ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; CELL ADHESION; COVALENT BOND; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; STRUCTURE ANALYSIS; THROMBOCYTE AGGREGATION;

ABO BLOOD-GROUP SYSTEM; COLLAGEN; HUMANS; ISOANTIGENS; PLATELET AGGREGATION; PROTEIN BINDING; RISTOCETIN; VON WILLEBRAND FACTOR;

EID: 0033867095     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.02113.x     Document Type: Article

References (32)

1. Andrew, R.K., Gorman, J.J., Booth, W.J., Corino, G.L., Castaldi, P.A. & Berndt, M.C. (1989) Cross-linking of monomeric 39/34 Da dispase fragment of von Willebrand factor (Leu-480-Gly-718) to the N-terminal region of alpha-chain of membrane glycoprotein Ib on intact platelets with Bis (sulfosuccinimidyl) suberate. Biochemistry, 28, 8326-8336.
2. Berkowitz, S.D. & Federici, A.B. (1988) Sialic acid prevents loss of large von Willebrand factor multimers by protecting against amino terminal proteolytic cleavage. Blood, 72, 1790-1798.
3. Blann, A.D. & McCollum, C.N. (1994) von Willebrand factor, endothelial cell damage and atherosclerosis. European Journal of Vascular Surgery, 8, 10-15.
4. Carew, J.A., Quinn, S.M., Stoddart, J.H. & Lynch, D.C. (1992) O-linked carbohydrate of recombinant von Willebrand factor influences Ristocetin-induced binding to platelet glycoprotein Ib. Journal of Clinical Investigation, 90, 2258-2267.
5. Erikssen, J., Thaulow, E., Stormorken, H., Brendemoen, O. & Hellem, A. (1980) ABO blood groups and coronary heart disease (CHD). A study in subjects with severe and latent CHD. Thrombosis and Haemostasis, 43, 137-140.
6. Federici, A.B., Elder, J.H., De Marco, L., Ruggeri, Z.M. & Zimmerman, T.S. (1984) Carbohydrate moiety of von Willebrand factor is not necessary for maintaining multimeric structure and ristocetin cofactor activity but protects from proteolytic degradation. Journal of Clinical Investigation, 74, 2049-2055.
7. Fujimura, Y., Holland, L.Z., Ruggeri, Z.M. & Zimmerman, T.S. (1987) The von Willebrand factor domain-mediating botrocetin-induced binding to glycoprotein IB lies between Val449 and Lys728. Blood, 70, 985-988.
8. Gill, J.C., Endres-Brooks, J., Bauer, P.J., Marks, Jr, W.J. & Montgomery, R.R. (1987) The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood, 69, 1691-1695.
9. Goudemand, J., Mazurier, C., Samor, B., Bouquelet, S., Montreuil, J. & Goudemand, M. (1985) Effect of carbohydrate modifications of factor VIII/von Willebrand factor on binding to platelets. Thrombosis and Haemostasis, 53, 390-395.
10. Gralnick, H.R. (1978) Factor VIII/von Willebrand factor protein. Galactose, a cryptic determinant of von Willebrand factor activity. Journal of Clinical Investigation, 62, 496-499.
11. Ionescu, D.A., Marcu, I. & Bicescu, E. (1976) Cerebral thrombosis, cerebral hemorrhage, and ABO blood-groups. Lancet, 1, 278-280.
12. Jansson, J.H., Nilsson, T.K., Johnson, O. (1991) Von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death. British Heart Journal, 66, 351-355.
13. Kao, K.J., Pizzo, S.V. & McKee, P.A. (1980) Factor VIII/von Willebrand protein: modification of its carbohydrate causes reduced binding to platelets. Journal of Biological Chemistry, 255, 10134-10139.
14. Kaul, D.K., Nagel, R.L., Chen, D. & Tsai, H.M. (1993) Sickle erythrocyte-endothelial interactions in microcirculation: the role of von Willebrand factor and implications for vasoocclusion. Blood, 81, 2429-2438.
15. Kominato, Y., McNeill, P.D., Yamamoto, M., Russell, M., Hakomori, S. & Yamamoto, F. (1992) Animal histo-blood group ABO genes. Biochemical and Biophysical Research Communications, 189, 154-164.
16. Matsui, T., Titani, K. & Mizuochi, T. (1992) Structures of the Asparagine-linked oligosaccharide chains of human von Willebrand factor: occurrence of blood group A, B and H (O) structures. Journal of Biological Chemistry, 267, 8723-8729.
17. Matsui, T., Fujimura, Y., Nishida, S. & Titani, K. (1993) Human plasma alpha2-macroglobulin and von Willebrand factor possess covalently linked ABO (H) blood group antigens in subjects with corresponding ABO phenotype. Blood, 82, 663-668.
18. Meade, T.W., Cooper, J.A., Stirling, Y., Ruddock, H.V. & Miller, G.J. (1994) Factor VIII, ABO blood group and the incidence of ischaemic heart disease. British Journal of Haematology, 88, 601-607.
19. Medalie, J.H., Levene, C., Papier, C., Goldbourt, U., Dreyfuss, F., Oron, D., Neufeld, H. & Riss, E. (1971) Blood groups, myocardial infarction and angina pectoris among 10,000 adult males. New England Journal of Medicine, 285, 1348-1353.
20. Meyer, D. & Girma, J.P. (1993) von Willebrand factor: structure and function. Thrombosis and Haemostasis, 70, 99-104.
21. Nierodzik, M.L., Kiepfish, A. & Karpatkin, S. (1995) Role of platelets, thrombin integrin IIb-IIIa, fibronectin and von Willebrand factor on tumour adhesion in vitro and metastasis in vivo. Thrombosis and Haemostasis, 74, 282-290.
22. Sodetz, J.M., Pizzo, S.V. & McKee, P.A. (1977) Relationship of sialic acid to function and in vivo survival of human factor VIII/von Willebrand factor protein. The Journal of Biological Chemistry, 252, 5538-5546.
23. Sweeney, J.D. & Hoernig, L.A. (1992) Intraplatelet von Willebrand factor and ABO blood group. Thrombosis Research, 68, 393-398.
24. Thompson, S.G., Kienast, J., Pyke, S.D.M., Haverkate, F. & Van De Loo, J.C.W. for the European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. (1995) Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. New England Journal of Medicine, 332, 635-641.
25. Titani, K., Kumar, S., Takio, K., Ericsson, L.H., Wade, R.D., Ashida, K., Walsh, K.A., Chopek, M.W., Sadler, J.E. & Fujikawa, K. (1986) Amino acid sequence of human von Willebrand factor. Biochemistry, 26, 8099-8109.
26. Tsai, H.M. (1996) Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and required calcium ion. Blood, 87, 4235-4244.
27. Tsai, H.M. & Lian, E.C. (1998) Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. New England Journal of Medicine, 339, 1629-1631.
28. Williams, S.B., McKeown, L.P., Krutzsch, H., Hansmann, K. & Gralnick, H.R. (1994) Purification and characterization of human platelet von Willebrand factor. British Journal of Haematology, 88, 582-591.
29. Witkop, Jr, C.J., Bowie, E.J., Krumwiede, M.D., Swanson, J.L., Plumhoff, E.A. & White, J.G. (1993) Synergistic effect of storage pool deficient platelets and low plasma von Willebrand factor on the severity of the hemorrhagic diathesis in Hermansky-Pudlak Syndrome. American Journal of Hematology, 44, 256-259.
30. Yamamoto, F., McNeill, P.D. & Hakomori, S. (1992) Human histoblood group A2 transferase coded by A2 allele, one of the A subtypes, is characterized by a single base deletion in the coding sequence, which results in an additional domain at the carboxyl terminal. Biochemical and Biophysical Research Communications, 187, 366-374.
31. Zhu, A. & Goldstein, J. (1995) Cloning and functional expression of cDNA encoding coffee bean alpha-galactosidase. Gene, 140, 227-231.
32. Zhu, A., Monahan, C., Wang, Z.K. & Goldstein, J. (1996) Expression, purification and characterization of recombinant alpha-N-acetylgalactosaminidase produced in the yeast Pichia pastoris. Protein Expression and Purification, 8, 456-462.